In patients with pyelonephritis, leukocytosis, C-reactive protein (CRP), and procalcitonin (PCT) are the most commonly used biomarkers for diagnosis and treatment monitoring [2,3,4]. This evidence concerns the gene CRP and Increased total leukocyte count.